|4Aug 16, 5:18 PM ET

Fuhrman Alan 4

4 · Tyra Biosciences, Inc. · Filed Aug 16, 2024

Insider Transaction Report

Form 4
Period: 2024-08-14
Fuhrman Alan
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-08-14+115,000115,000 total
    Exercise: $21.57Exp: 2034-08-13Common Stock (115,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option vest monthly following August 14, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4